Transforming Treatment:
A Vision for the Future
We at benfovir are united by a vision – the vision of a healthier future. We are working tirelessly to advance transketolase inhibition as a novel therapeutic strategy.
Viral Diseases
Developing new treatments for viral infections by targeting viral replication and boosting the immune system.
Inflammation
Addressing inflammatory conditions by restoring immune balance and reducing excessive inflammation.
Cancer
Developing innovative cancer therapies that target the metabolic vulnerabilities of cancer cells.
Benfovir: Advancing Next-Generation Therapeutics
We are committed to developing innovative therapies that target transketolase to address a range of diseases.
Research & Development
Our focus is on developing safe and effective transketolase inhibitors for various therapeutic applications.
Clinical Trials
We are committed to advancing our therapies through rigorous clinical trials to evaluate their safety and efficacy.
Future of Medicine
Benfovir aims to transform the treatment landscape for viral diseases and inflammation through transketolase inhibition.
Our Commitment to Innovation
At Benfovir, we are driven by a passion for scientific discovery and a commitment to improving human health.
Scientific Excellence
Our research is grounded in rigorous scientific principles and a deep understanding of disease mechanisms.
Patient-Centric Approach
We are dedicated to developing therapies that address unmet medical needs and improve patients‘ lives.
Collaborative Spirit
We believe in the power of collaboration and actively seek partnerships to advance scientific breakthroughs.
Scientific Excellence
Our research is grounded in rigorous scientific principles and a deep understanding of disease mechanisms.
Patient-Centric Approach
We are dedicated to developing therapies that address unmet medical needs and improve patients‘ lives.
Collaborative Spirit
We believe in the power of collaboration and actively seek partnerships to advance scientific breakthroughs.
Management and Advisors
Dr. Johannes Coy
CEO
Prof. Dr. Heinz Hänel
CDO
Maik Käbisch
Chairman Of The Supervisory Board
Join Us on the Journey
Together, let’s transform the treatment landscape for viral diseases, inflammation, and cancer.
benfovir AG
Gräfenhäuser Str. 26
64293 Darmstadt
Germany
Tel +49 (0) 6151 – 86179 – 20
Fax +49 (0) 6151 – 86179 – 21
info@benfovir.com